Literature DB >> 28385359

Mortality, rehospitalizations and costs in children undergoing a cardiac procedure in their first year of life in New South Wales, Australia.

Claire M Lawley1, Samantha J Lain2, Gemma A Figtree3, Gary F Sholler4, David S Winlaw4, Christine L Roberts2.   

Abstract

BACKGROUND: Cardiac procedures are part of management for many children with congenital heart disease (CHD). Using population health data, this study explores health outcomes of children undergoing a cardiac procedure in the first year of life to better understand the impact of CHD on children, families and health services. METHODS AND
RESULTS: A population-based record-linkage cohort study was undertaken. Rate of cardiac procedures in the first year of life over the study period 2001-2012 in New South Wales, Australia, was steady at 2.5 children per 1000 live births, accounting for 2722 children. Excluding those with isolated closure of patent ductus arteriosus (n=416), 50% required readmission in the first year of life. Over 1/5th had an additional non-cardiac congenital anomaly. Average total cost per infant for initial procedure admission was $67,054 AUD ($63,124-$70,984) with a median length of stay (LOS) 13days (IQR 8-23). Average cost per readmission in the first year of life was $11,342 (95% CI 10,361-$12,323) with median LOS 2days (IQR 1-5). Mortality rate in the 30days following initial procedure was 3.1% (72/2306). Mortality rate by age 1year was 7.1%, and 13.8% for those who had neonatal surgery.
CONCLUSION: Risk of mortality in operatively-managed CHD extends beyond the immediate perioperative period. Children undergoing a cardiac procedure in their first year are often readmitted to hospital for both further planned procedures and unplanned reasons such as infection. These readmissions capture the significant impact of illness and pose substantial financial cost to the health system.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cardiac catheterization; Cardiac surgery; Congenital heart disease; Health services research; Pediatrics

Mesh:

Year:  2017        PMID: 28385359     DOI: 10.1016/j.ijcard.2017.03.113

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  3 in total

1.  Novel Biomarkers Improve Prediction of 365-Day Readmission After Pediatric Congenital Heart Surgery.

Authors:  Devin M Parker; Allen D Everett; Meagan E Stabler; Luca Vricella; Marshall L Jacobs; Jeffrey P Jacobs; Chirag R Parikh; Sara K Pasquali; Jeremiah R Brown
Journal:  Ann Thorac Surg       Date:  2019-07-16       Impact factor: 4.330

2.  Biomarkers improve prediction of 30-day unplanned readmission or mortality after paediatric congenital heart surgery.

Authors:  Jeremiah R Brown; Meagan E Stabler; Devin M Parker; Luca Vricella; Sara Pasquali; JoAnna K Leyenaar; Andrew R Bohm; Todd MacKenzie; Chirag Parikh; Marshall L Jacobs; Jeffrey P Jacobs; Allen D Everett
Journal:  Cardiol Young       Date:  2019-07-10       Impact factor: 1.093

3.  Influence of Geographic Access on Surgical Center Readmissions After Index Congenital Heart Surgery.

Authors:  Nelangi M Pinto; L LuAnn Minich; Minkyoung Yoo; Alisha Floyd; Jacob Wilkes; James VanDerslice; Melissa Yamauchi; Richard Nelson
Journal:  J Pediatr       Date:  2021-03-24       Impact factor: 6.314

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.